Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,758 | 34 | 50.0% |
| Honoraria | $600.00 | 1 | 17.1% |
| Education | $598.37 | 7 | 17.0% |
| Consulting Fee | $562.50 | 1 | 16.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $928.63 | 8 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $562.50 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $375.04 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $340.82 | 5 | $0 (2024) |
| Exelixis Inc. | $276.20 | 3 | $0 (2024) |
| Seagen Inc. | $223.47 | 3 | $0 (2023) |
| Daiichi Sankyo Inc. | $154.60 | 4 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $152.17 | 2 | $0 (2024) |
| Gilead Sciences, Inc. | $119.60 | 1 | $0 (2023) |
| Aveo Pharmaceuticals, Inc. | $91.40 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,212 | 22 | PFIZER INC. ($818.09) |
| 2023 | $526.02 | 10 | Seagen Inc. ($121.87) |
| 2022 | $452.66 | 6 | Astellas Pharma US Inc ($125.00) |
| 2021 | $327.78 | 5 | AstraZeneca Pharmaceuticals LP ($297.84) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 09/21/2024 | Astellas Pharma Global Development | Padcev (Drug) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: Oncology | ||||||
| 09/13/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Oncology | ||||||
| 09/06/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: HORMONE THERAPY | ||||||
| 08/28/2024 | Janssen Scientific Affairs, LLC | AKEEGA (Drug) | Consulting Fee | Cash or cash equivalent | $562.50 | General |
| Category: Oncology | ||||||
| 08/22/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $85.05 | General |
| 07/09/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Education | In-kind items and services | $91.40 | General |
| Category: Oncology | ||||||
| 05/31/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $39.86 | General |
| Category: ONCOLOGY | ||||||
| 05/24/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Oncology | ||||||
| 04/18/2024 | Exelixis Inc. | — | Food and Beverage | In-kind items and services | $125.40 | General |
| 03/22/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: HORMONE THERAPY | ||||||
| 03/15/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: ONCOLOGY | ||||||
| 03/02/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.32 | General |
| 02/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $135.50 | General |
| Category: Oncology | ||||||
| 02/09/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: ONCOLOGY | ||||||
| 02/03/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Oncology | ||||||
| 01/26/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $136.78 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 01/25/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $135.00 | General |
| 01/19/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $65.99 | General |
| 01/19/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Oncology | ||||||
| 01/04/2024 | PFIZER INC. | PADCEV (Biological) | Honoraria | Cash or cash equivalent | $600.00 | General |
| Category: Oncology | ||||||
| 11/18/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: Oncology | ||||||
| 10/27/2023 | Seagen Inc. | — | Education | In-kind items and services | $99.95 | General |
| 10/27/2023 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 58 | 86 | $15,516 | $4,510 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 37 | 56 | $8,736 | $2,500 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 21 | 30 | $6,780 | $2,010 | 29.7% |
About Helda Bacall, FNP-C
Helda Bacall, FNP-C is a Family healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2020. The National Provider Identifier (NPI) number assigned to this provider is 1134731466.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Helda Bacall, FNP-C has received a total of $3,519 in payments from pharmaceutical and medical device companies, with $2,212 received in 2024. These payments were reported across 43 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,758).
As a Medicare-enrolled provider, Bacall has provided services to 58 Medicare beneficiaries, totaling 86 services with total Medicare billing of $4,510. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Detroit, MI
- Active Since 08/18/2020
- Last Updated 08/18/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1134731466
Products in Payments
- PADCEV (Biological) $739.02
- AKEEGA (Drug) $562.50
- XTANDI (Drug) $178.13
- Nubeqa (Drug) $152.17
- Xtandi (Drug) $151.00
- CABOMETYX (Drug) $150.80
- Trodelvy (Drug) $119.60
- IMFINZI (Biological) $114.30
- FOTIVDA (Drug) $91.40
- RYBREVANT (Drug) $74.99
- ORGOVYX (Drug) $67.50
- Lenvima (Drug) $49.19
- LYNPARZA (Drug) $42.98
- Enhertu (Drug) $29.94
- Padcev (Drug) $28.76
- PLUVICTO (Drug) $23.75
- ENHERTU (Drug) $11.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Detroit
Elisheva Ellenberg, Fnp-C, FNP-C
Family — Payments: $92,393
Erin Hamel, Fnp-Bc, FNP-BC
Family — Payments: $5,541
Mrs. Nancy Welke, Np, NP
Family — Payments: $4,243
Lisa Brinker, Rn, RN
Family — Payments: $4,175
Mrs. Sharlet Geevarughese, Np-C, NP-C
Family — Payments: $3,972
Laura Rysso, Fnp-Bc, FNP-BC
Family — Payments: $3,730